BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 31097291)

  • 1. HPV status in women with high-grade dysplasia on cervical biopsy and preceding negative HPV tests.
    Ge Y; Mody RR; Olsen RJ; Zhou H; Luna E; Armylagos D; Puntachart N; Hendrickson H; Schwartz MR; Mody DR
    J Am Soc Cytopathol; 2019; 8(3):149-156. PubMed ID: 31097291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-grade squamous intraepithelial lesion cervicovaginal paps with negative high-risk HPV testing, a prospective study with histological follow-up.
    Agoff SN; Brockmeyer AD; Barrie AM; Larson J
    Diagn Cytopathol; 2023 Aug; 51(8):475-479. PubMed ID: 37086174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-grade squamous intraepithelial lesion on Papanicolaou test: follow-up rates and stratification of risk for high-grade squamous intraepithelial lesion.
    Rufail M; Lew M; Pang J; Jing X; Heider A; Cantley RL
    J Am Soc Cytopathol; 2020; 9(4):258-265. PubMed ID: 32402830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPV-ISH-Negative Invasive Cervical Squamous Cell Carcinoma: Histologic and Pap Test Results.
    Alexander C; White M; Maleki Z; Rodriguez EF
    Acta Cytol; 2019; 63(5):417-423. PubMed ID: 31195388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the diagnostic value of cervical cytology and HPV HR DNA testing for the diagnosis of low-grade and high-grade squamous intraepithelial lesions across different age groups.
    Paluszkiewicz A; Pruski D; Iwaniec K; Kędzia W
    Ginekol Pol; 2017; 88(3):141-146. PubMed ID: 28397203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High grade squamous intraepithelial lesion on high-risk HPV negative patients: Why we still need the Pap test.
    Sun H; Masand RP; Patel SJ; Padmanabhan V
    Diagn Cytopathol; 2018 Nov; 46(11):908-913. PubMed ID: 30488672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possibly carcinogenic HPV subtypes are a cause of HSIL and negative clinical HPV tests - A European prospective single center study.
    Reich O; Regauer S; Kashofer K
    Gynecol Oncol; 2020 Jul; 158(1):112-116. PubMed ID: 32354471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Punch biopsy guided by both colposcopy and HR-HPV status is more efficient for identification of immediate high-grade squamous intraepithelial lesion or worse among HPV-infected women with atypical squamous cells of undetermined significance.
    Ding Z; Li Y; Chen A; Song M; Zhang Y
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():32-36. PubMed ID: 27816739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histomorphologic assessment and distribution of high-risk human papillomavirus (HPV) types in cervical high-grade squamous intraepithelial lesions with unusual histomorphologic features.
    Gutnik H; Kastelic P; Oštrbenk Valenčak A; Poljak M; Strojan Fležar M
    Virchows Arch; 2020 Feb; 476(2):251-260. PubMed ID: 31754816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reporting rates of atypical glandular cells and their HPV testing and histologic follow-up results: a comparison between ThinPrep and SurePath preparations from a single academic institution.
    Liu S; Gibbons-Fideler IS; Tonkovich D; Shen R; Li Z
    J Am Soc Cytopathol; 2019; 8(3):128-132. PubMed ID: 31097288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and Associated Factors of Abnormal Cervical Cytology and HighRisk HPV DNA among Bangkok Metropolitan Women.
    Tangjitgamol S; Kantathavorn N; Kittisiam T; Chaowawanit W; Phoolcharoen N; Manusirivithaya S; Khunnarong J; Srijaipracharoen S; Saeloo S; Krongthong W; Supawattanabodee B; Thavaramara T; Pataradool K
    Asian Pac J Cancer Prev; 2016; 17(7):3147-53. PubMed ID: 27509943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immediate biopsy of cervical cytology-negative and non-HPV-16/18 oncogenic types positive patients.
    Karaca İ; Öztürk M; Comba C; Demirayak G; Alay İ; Erdoğan VŞ; Hoşgören M; Yaşar L
    Diagn Cytopathol; 2018 Apr; 46(4):326-330. PubMed ID: 29460502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of high-risk HPV genotyping in women with high-grade cervical lesions: evidence for improving the cervical cancer screening strategy in China.
    Xu H; Lin A; Shao X; Shi W; Zhang Y; Yan W
    Oncotarget; 2016 Dec; 7(50):83775-83783. PubMed ID: 27626178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ideal strategy for cervical cancer screening in Japan: Result from the Fukui Cervical Cancer Screening Study.
    Kurokawa T; Onuma T; Shinagawa A; Chino Y; Kobayashi M; Yoshida Y
    Cytopathology; 2018 Aug; 29(4):361-367. PubMed ID: 29768678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-risk human papillomavirus detection in women with low-grade squamous intraepithelial lesions or higher-grade cytology using the Cervista HPV HR test.
    Gold MA; Thomas MA; Huh WK; Sarto GE; Day SP
    J Low Genit Tract Dis; 2013 Jan; 17(1):51-7. PubMed ID: 22885641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study.
    Nakamura Y; Matsumoto K; Satoh T; Nishide K; Nozue A; Shimabukuro K; Endo S; Nagai K; Oki A; Ochi H; Morishita Y; Noguchi M; Yoshikawa H
    Int J Clin Oncol; 2015 Oct; 20(5):974-81. PubMed ID: 25652908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern Thailand.
    Khunamornpong S; Settakorn J; Sukpan K; Suprasert P; Srisomboon J; Intaraphet S; Siriaunkgul S
    PLoS One; 2016; 11(6):e0158184. PubMed ID: 27336913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus testing for triage of women with low-grade squamous intraepithelial lesions.
    Cuzick J; Thomas Cox J; Zhang G; Einstein MH; Stoler M; Trupin S; Behrens CM
    Int J Cancer; 2013 Feb; 132(4):959-66. PubMed ID: 22806936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPV-based screening for cervical cancer among women 55-59 years of age.
    Bergengren L; Lillsunde-Larsson G; Helenius G; Karlsson MG
    PLoS One; 2019; 14(6):e0217108. PubMed ID: 31199811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. hrHPV positivity in ASC-US Papanicolaou tests from women with treated HPV- and non-HPV-related gynecologic malignancies.
    Paintal A; Heagley D
    J Am Soc Cytopathol; 2016; 5(4):216-220. PubMed ID: 31042511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.